DKSH Indonesia strengthens its commitment to quality control, compliance, and safety in the pharmaceutical industry by obtaining a new license from the National Agency of Drug and Food Control (BPOM).
Jakarta, Indonesia, June 5, 2023 – DKSH's Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients, has obtained a new license for its pharmaceutical industry business line from the National Agency of Drug and Food Control (BPOM) in Indonesia.
DKSH has a long-standing reputation for excellence in the global pharmaceutical industry. This license enables DKSH Indonesia's pharmaceutical team to expand its service offering, including regulatory, distribution, and global sourcing, for a wide range of high-quality pharmaceutical ingredients, including Active Pharmaceutical Ingredients (APIs) and excipients.
Ranti Endriani, Manager, Pharmaceutical Industry, DKSH Indonesia, stated: "We are delighted to receive this new license from BPOM, which recognizes our commitment to providing safe and effective pharmaceutical products to the Indonesian market. This license is a testament to our strong quality control systems, experienced technical expertise, and dedication to compliance with all relevant laws and regulations governing the pharmaceutical industry.”
Chookitch Thanakitkachorn, General Manager Performance Materials, DKSH Indonesia, added: "We are committed to maintaining the highest standards of quality and safety in everything we do, and this license from the National Agency of Drug and Food Control will enable us to continue to enrich people's lives in Indonesia with the best possible pharmaceutical ingredients."